2 days Longboard Pharmaceuticals (NASDAQ:LBPH) Earns “Neutral” Rating from Cantor FitzgeraldMarketBeat
Cantor Fitzgerald reissued a “neutral” rating on shares of Longboard Pharmaceuticals in a report on Monday.
XCantor Fitzgerald reissued a “neutral” rating on shares of Longboard Pharmaceuticals in a report on Monday.
X